openPR Logo
Press release

Prominent Enteric Disease Testing Market Trend for 2025: Advancements in Enteric Disease Testing: The Role of Laboratory Tools in Enhancing Diagnostic Accuracy

02-21-2025 01:41 PM CET | Health & Medicine

Press release from: The Business Research Company

Enteric Disease Testing Market

Enteric Disease Testing Market

What market dynamics are playing a key role in accelerating the growth of the enteric disease testing market?
The escalation in diarrhea and hemolytic urea syndrome (HUS) cases are anticipated to boost the evolution of the enteric disease testing market in the future. The primary factor leading to diarrhea is the intake of polluted food and water. The blood and blood vessels are predominantly affected by the condition HUS, which is most prevalent among children suffering from diarrhea. Diarrhea and HUS are prominent reasons for fatalities among children below five years of age. The surge in diarrhea and hemolytic cases necessitates testing solutions, thereby enhancing the demand for enteric disease testing solutions. As per the Centers for Disease Control and Prevention, diarrhea is responsible for being the second highest cause of deaths among children less than 5 years old, accounting for one out of every nine child deaths yearly with 801 thousand cases globally. Consequently, the rising occurrences of enteric diseases will fuel the expansion of the enteric disease testing market.

Get Your Enteric Disease Testing Market Report Here:
https://www.thebusinessresearchcompany.com/report/enteric-disease-testing-global-market-report

How will the growth rate of the enteric disease testing market shape industry trends by 2034?
The market size of enteric disease testing has witnessed robust growth in the past few years. The projection indicates it will rise from $4.62 billion in 2024 to $4.87 billion in 2025, with a compound annual growth rate (CAGR) of 5.4%. The historical growth is mainly due to concerns related to water and food safety, numerous outbreaks and epidemics, the globalization of food supply, the rise in travel-related infections, and regulatory standards.

The market for enteric disease testing is projected to exhibit significant growth in the coming years, expanding to a value of $6.29 billion in 2029 with a compound annual growth rate (CAGR) of 6.6%. The growth expected during the forecast period is due to factors such as the inclusion of telemedicine and remote monitoring, impacts of climate change, cross-sector collaboration, antimicrobial resistance, and the rise in enteric pathogens. The forecast period will also experience key trends such as the use of molecular diagnostics, the integration of digital health, the application of artificial intelligence and machine learning, the increased use of syndromic testing, and point-of-care testing.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=6118&type=smp

What trends are poised to drive the future success of the enteric disease testing market?
Key players in the enteric disease testing market are honing their focus on creating advanced diagnostic solutions, such as specific laboratory instruments, in order to increase diagnostic accuracy and improve patient outcomes. These lab tools, used predominantly in scientific and medical labs to conduct tests, analyze samples, and provide precise data for diagnosis, are critical for optimising the precision of diagnostic procedures and aiding research in different areas, such as enteric disease testing. For example, Jiangsu Bioperfectus Technologies Co., Ltd., a biotech firm based in China, introduced real-time PCR kits in March 2023, tailored explicitly for diagnosing gastrointestinal infectious diseases. These kits offer enhanced sensitivity and specificity, facilitating precise detection of minute quantities of nucleic acids in an array of samples. In addition, they enable quick analysis, considerably shrinking processing times and enhancing throughput in both diagnostic and research sectors.

Which primary segments of the enteric disease testing market are driving growth and industry transformations?
The enteric disease testing market covered in this report is segmented -

1) By Disease Type: Bacterial Enteric Disease, Parasitic Enteric Disease, Viral Enteric Disease, Other Disease Types
2) By Technology: Traditional, Rapid, Convenience-Based, Polymerase Chain Reaction (PCR), Immunoassay, Chromatography And Spectrometry, Other Technologies
3) By Application: Hospitals, Research Centers, Clinics, Other Applications

Subsegments:
1) By Bacterial Enteric Disease: Salmonella, Escherichia coli (E. coli), Shigella, Campylobacter, Clostridium Difficile (C. diff)
2) By Parasitic Enteric Disease: Giardia lamblia, Entamoeba histolytica, Cryptosporidium, Trichinella spiralis
3) By Viral Enteric Disease: Norovirus, Rotavirus, Adenovirus, Astrovirus
4) By Other Disease Types: Fungal Enteric Infections, Foodborne Illnesses, Antibiotic-Associated Diarrhea

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=6118

Which geographical regions are pioneering growth in the enteric disease testing market?
North America was the largest region in the enteric disease testing market in 2024. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the enteric disease testing market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Who are the influential players reshaping the enteric disease testing market landscape?
Major companies operating in the enteric disease testing market include Becton Dickinson and Company, Biomerica Inc., bioMérieux SA, Bio-Rad Laboratories Inc., Cepheid Inc., Coris Bioconcept, DiaSorin Molecular LLC, MMeridian Life Science Inc., Trinity Biotech plc., Abbott Laboratories, Fisher Scientific Inc., Alere Inc., 3M Company., Asure Quality, Bureau Veritas, Meridian Bioscience Inc., Hologic Inc., Luminex Corporation, Nanosphere Inc., Quidel Corporation, Roche Diagnostics, Siemens Healthcare Diagnostics Inc., Vela Diagnostics, GenMark Diagnostics, BioFire Diagnostics LLC, Veredus Laboratories Pte Ltd.

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/customise?id=6118&type=smp

What Is Covered In The Enteric Disease Testing Global Market Report?

•Market Size Forecast: Examine the enteric disease testing market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the enteric disease testing market for a structured understanding.
•Key Players Overview: Analyze major players in the enteric disease testing market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the enteric disease testing market.
•Segment Contributions: Evaluate how different segments drive overall growth in the enteric disease testing market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the enteric disease testing market.
•Industry Challenges: Identify potential risks and obstacles affecting the enteric disease testing market.
•Competitive Landscape: Review strategic developments in the enteric disease testing market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Prominent Enteric Disease Testing Market Trend for 2025: Advancements in Enteric Disease Testing: The Role of Laboratory Tools in Enhancing Diagnostic Accuracy here

News-ID: 3881180 • Views:

More Releases from The Business Research Company

Competitive Analysis: Leading Companies and New Entrants in the Wire Arc Additive Manufacturing Cell Market
Competitive Analysis: Leading Companies and New Entrants in the Wire Arc Additiv …
The wire arc additive manufacturing cell market is rapidly gaining traction as industries increasingly embrace advanced metal 3D printing technologies. With significant investments and technological breakthroughs, this sector is set to experience remarkable growth, transforming manufacturing processes across multiple fields. Let's explore the market's size, influential players, key trends, and segmentation to understand its future trajectory. Projected Expansion of the Wire Arc Additive Manufacturing Cell Market The wire arc additive manufacturing cell
Future Perspectives: Key Trends Shaping the Viscosupplementation Treatment for Arthritis Market Until 2029
Future Perspectives: Key Trends Shaping the Viscosupplementation Treatment for A …
The viscosupplementation treatment for arthritis market is on the verge of significant expansion, driven by advances in medical technology and a growing demand for effective arthritis therapies. With increasing awareness around early intervention and new treatment options, this sector is poised for rapid development over the coming years. Let's explore the market size, key players, emerging trends, and segment-wise forecasts that define this growing industry. Projected Market Growth and Size of
Segmentation, Major Trends, and Competitive Overview of the Viral Vector Development Service Market
Segmentation, Major Trends, and Competitive Overview of the Viral Vector Develop …
The viral vector development service market is set to experience substantial growth in the coming years, driven by technological progress and increasing demand from various sectors. As gene therapies and advanced treatments gain prominence, the need for efficient viral vector production and development is becoming more critical. Let's explore the market size projections, key players, emerging trends, and the segment structure shaping this industry's future. Projected Expansion and Market Size of
Competitive Landscape: Leading Companies and New Entrants in the Transient Elastography Market
Competitive Landscape: Leading Companies and New Entrants in the Transient Elast …
The transient elastography market is poised for substantial expansion as advancements in healthcare diagnostics continue to evolve. Increasing emphasis on non-invasive techniques and early disease detection is driving widespread adoption, setting the stage for strong market growth in the coming years. Let's explore the current market valuation, leading players, emerging innovations, and key segments shaping this industry. Projected Market Value and Growth of the Transient Elastography Market The transient elastography market is

All 5 Releases


More Releases for Disease

Protheragen Announces Disease Model Development Services to Enhance Rare Disease …
Protheragen announced the release of its disease model development services provided to enhance rare disease research. With an increasing focus on rare diseases and the need for tailored research models, Protheragen is dedicated to providing cutting-edge solutions to support this important area of medical research. Rare diseases, which affect a small percentage of the population, pose unique challenges for researchers due to their limited understanding and lack of available treatment options.
Biopharmaceutical Fermentation Market 2022 | Growing Morbidity of Genetic Diseas …
According to Precision Business Insights (PBI), the latest report, the biopharmaceutical fermentation market is expected to be valued at USD 10,302.1 million in 2022, growing at a 4.7% CAGR from 2022 to 2028. The growing prevalence of chronic illness, cancer, cardiac diseases, infectious diseases, antibiotic resistance, autoimmune diseases, etc., globally causes the leaning toward biopharmaceutical products, which show promising results in the research studies. Moreover, new findings by the
Global Inflammatory Bowel Disease (IBD) Market Key Players Analysis, Disease Ind …
Global Inflammatory Bowel Disease (IBD) Market, valued at USD 210.5 Billion in the year 2020 has been driven by factors such as the increasing prevalence of Ulcerative Colitis and Crohn’s Disease, advances in medical technology, government support for inflammatory bowel disease treatment research, and the ubiquity of anxiety and depression. Moreover, factors such as the irregular food habits, unhealthy lifestyle of people, increased level of pollution and increase in alcohol
Moyamoya Disease Market - A Scientometric Assessment of Disease During 2018-23
Market Highlight: Moyamoya disease (MMD) is a chronic, cerebrovascular disease characterized by progressive stenosis in the internal carotid artery and an abnormal vascular network at the base of the brain. The stroke is one of the significant symptoms of moyamoya disease, which further leads to paralysis of the face, arms, and legs, loss of speech, and temporary loss of neurologic function of body parts, visual disturbances, headaches, developmental delay, and
Refsum Disease Industry An Overview of A New Disease - 2018
"Refsum Disease" is a genetic disorder which is inherited as an autosomal recessive trait. The condition is characterized by progressive loss of vision (retinitis pigmentosa), failure of muscle coordination (ataxia), degenerative nerve disease (peripheral neuropathy), and dry, rough, scaly skin (ichthyosis). The accumulation of fatty acid (phytanic acid) in blood plasma and tissues is the main cause of refsum disease. This occurs due to malfunction of the enzyme producing gene
Chagas Disease (Infectious Disease) Pipeline Forecast Report, H1, 2017 [MRH]
Market Research Hub's Pharmaceutical and Healthcare latest pipeline guide Chagas Disease - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Chagas Disease Market (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and